DIRECTORS' REPORT
To the Members Your Directors have pleasure in presenting the Sixty-fourth Annual Report of the Company together with the audited accounts for the year ended 31st March, 2012. The audited figures given hereunder for the financial year under review and the previous period are not comparable, as the current period is for 12 (twelve) months from 1st April, 2011 up to 31st March, 2012, while the previous period was for a period of 16 (sixteen) months from 1st December, 2009 to 31st March, 2011. FINANCIAL HIGHLIGHTS (` in Lakhs) Apr 2011Mar 2012 Revenue from Operations (Net) Operating and Other Income Profit before non-recurring expenses Voluntary Retirement Scheme Profit before Taxation Provision for Tax Net Profit Balance brought forward from previous period Profit available for appropriation Dividend - Interim - Proposed Tax on Dividend - Interim - Proposed Transfer to General Reserve Balance carried to next year DIVIDEND Your Directors recommend a dividend of ` 18.00 (180%), previous year ` 22.00 (220%) per equity share. If the proposed dividend is approved by the Shareholders at the Annual General Meeting, the total dividend payout will be ` 4089.62 lakhs. Tax on dividend payout to be borne by the Company will aggregate ` 663.44 lakhs. The dividend will not suffer tax in the hands of the Shareholders. 663.44 1446.94 33465.02 548.47 258.01 806.48 1652.93 25195.62 4089.62 3408.01 1590.40 4998.41 58406.53 3841.32 20537.59 45.90 20491.69 6022.29 14469.40 25195.62 39665.02
Dec 2009-

Mar 2011 63648.41 2468.05 23798.73 230.98 23567.75 7038.45 16529.30 16124.14 32653.44

10

Wyeth Limited
KEY STATISTICS
Dividend (`)
35 Dividend
32.50 30.00

Sales & Profit After Tax (` in Lakhs)
80000 70000 60000 Sales PAT
16529 14469

20000 17000 14000
9967 8148

Dividend per Share (`)

30 25 20 15 10 5

20.00 18.00

Sales

22.00

50000 40000
33132

11000
5901

8000
63648 58407

38265

20000

28636

30000

5000 2000

0

Mar-08

Mar-09

Nov-09

Mar-11

Mar-12

Mar-08

Mar-09 Nov-09 Mar-11 Period ended

Mar-12

Period ended

Book Value Per Share (`)
260 220
Book Value
212 169
80 30.00

EPS & DPS (`)
EPS
32.50

DPS
72.75 63.69 20.00 22.00 18.00 25.97 35

180 140 100 60 20
114 120 122

60 50 40 30 20 10 0 35.86 43.87

25 20 15 10 5

Mar-08

Mar-09

Nov-09

Mar-11

Mar-12

0

Mar-08

Mar-09

Nov-09

Mar-11

Mar-12

Period ended

Period ended

Networth (` in Lakhs)
Networth 60000 50000
48193 38477
8%

How Rupee Earned was spent
15% 34%

Material Cost Employee Cost Manufacturing and Other expenses Finance Cost & Depreciation

Networth (` in Lakhs)

40000 30000 20000 10000 0
Mar-08 Mar-09 Nov-09
25840 27168 27752

10%

Taxes Dividend
1% 6%

Reserves

Mar-11

Mar-12
26%

Period ended

Dividend Per Share

Earning Per Share

70

30

Profit After Tax

11

DIRECTORS Mr. K. K. Maheshwari and Mr. S. S. Lalbhai retire by rotation at the forthcoming Annual General Meeting and being eligible, offer themselves for re-appointment. Mr. Sekhar Natarajan was appointed as Additional Director of the Company with effect from 5th August, 2011. In terms of Section 260 of the Companies Act, 1956, the term of office of Mr. Natarajan expires on the date of the forthcoming Annual General Meeting and he is eligible for appointment. Mr. S. Sridhar was appointed as Additional Director of the Company with effect from 21st May, 2012. In terms of Section 260 of the Companies Act, 1956, the term of office of Mr. Sridhar expires on the date of the forthcoming Annual General Meeting and he is eligible for appointment. Mr. Aijaz Tobaccowalla was appointed as Additional Director of the Company with effect from 28th June, 2012. In terms of Section 260 of the Companies Act, 1956, the term of office of Mr. Tobaccowalla expires on the date of the forthcoming Annual General Meeting and he is eligible for appointment. Mr. Kewal Handa has resigned as the Managing Director and Director of the Company with efffect from end of day, 15th August, 2012. Your Directors wish to place on record their appreciation of the valuable contribution made by Mr. Handa. The Board has appointed Mr. Aijaz Tobaccowalla as Managing Director with effect from commencement of business, 16th August, 2012, subject to the approval of the Members at the forthcoming Annual General Meeting and also subject to the approval of the Central Government. DIRECTORS' RESPONSIBILITY STATEMENT Pursuant to Section 217(2AA) of the Companies Act, 1956, the Directors confirm that: i) in the preparation of the annual accounts, the applicable accounting standards have been followed;

ii) appropriate accounting policies have been selected and applied consistently, and have made judgments and estimates that are reasonable and prudent so as to give a true and fair view of the state of affairs of the Company as at 31st March, 2012, and of the profit of the Company for the period 1st April, 2011 to 31st March, 2012; iii) proper and sufficient care has been taken for the maintenance of adequate accounting records in accordance with the provisions of the Companies Act, 1956, for safeguarding the assets of the Company and for preventing and detecting fraud and other irregularities; iv) the annual accounts have been prepared `on a going concern basis'. INFORMATION PURSUANT TO SECTION 217(2A) OF THE COMPANIES ACT, 1956 The information required under Section 217(2A) of the Companies Act, 1956, ("the Act") read with the Companies (Particulars of Employees) Rules, 1975, as amended, forms part of this Report. However, as per the provisions of Section 219 (1) (b) (iv) of the Act, the Report and Accounts are being sent to all shareholders excluding the statement of particulars of employees under Section 217(2A) of the Act. Any shareholder interested in obtaining a copy of the statement may write to the Company Secretary at the Company's Registered Office. CORPORATE GOVERNANCE The Management Discussion and Analysis Report and a Report on Corporate Governance along with a Certificate from Messrs. B S R & Associates, regarding compliance with the conditions of Corporate Governance pursuant to Clause 49 of the Listing Agreements with the Stock Exchanges are annexed hereto.

12

Wyeth Limited
CONSERVATION OF ENERGY, TECHNOLOGY ABSORPTION AND FOREIGN EXCHANGE EARNINGS AND OUTGOINGS The particulars required under Section 217(1)(e) of the Companies Act, 1956, read with the Companies (Disclosure of Particulars in the Report of Board of Directors) Rules, 1988, are annexed hereto as Annexure I. AUDITORS The Auditors, Messrs. B S R & Associates, retire at the conclusion of this Annual General Meeting and offer themselves for re-appointment. Messrs. B S R & Associates have confirmed their eligibility for re-appointment under Section 224(1B) of the Companies Act, 1956. Messrs. B S R & Associates, if appointed, will hold office up to the conclusion of the next Annual General Meeting of the Company. AUDITORS' COMMENTS The claims under the Drug Prices Equalization Account and the comments of the Auditors regarding the amount payable into the Drug Prices Equalization Account in respect of De-methyl Chlor Tetracycline, Chlor Tetracycline Hydrochloride, Tetracycline Hydrochloride, Dexamethasone, Amoxycillin Trihydrate, Benzathine Penicillin G and their formulations and claims by the Government regarding non-compliance with respect to prices fixed under Para 8 of the Drugs (Prices Control) Order, 1995, for Prednisolone based formulations have been explained in Notes 26(i)(a) and (b) to the Accounts. An early resolution of this issue will provide much needed clarity for the future. COST AUDITORS Pursuant to the provisions of Section 233B of the Companies Act, 1956, companies are required to file their Cost Audit Reports within 180 days from the close of the financial year. The Cost Audit Report for Formulations for the financial year ended 31 st March, 2011, was filed on 26th September, 2011. The Directors have appointed Messrs. RA & Co., Mumbai, as Cost Auditors to conduct the cost audit of Formulations for the year ended 31st March, 2012. ACKNOWLEDGEMENTS Your Directors take this opportunity to thank the Management of the Parent Company, for their valuable guidance and support. The Directors record their thanks to the Company's employees at all levels for their dedication and commitment throughout the year. The Directors would also like to record their thanks to the Company's shareholders, bankers, financial institutions, Central and State Government officials, medical professionals, hospitals, research institutions, vendors, trade and all customers for their continued support and co-operation. On behalf of the Board of Directors

Place: Mumbai Date: 28th June, 2012

Kewal Handa Managing Director

Sekhar Natarajan Director

13

